Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA’s Adverse Event Reporting System

Detalles Bibliográficos
Autores principales: Pistor, Maximilian, Hoepner, Andreas G F, Lin, Yanan, Jung, Simon, Bassetti, Claudio L, Chan, Andrew, Salmen, Anke, Hoepner, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600608/
https://www.ncbi.nlm.nih.gov/pubmed/34285050
http://dx.doi.org/10.1136/annrheumdis-2021-220679
_version_ 1784601189061492736
author Pistor, Maximilian
Hoepner, Andreas G F
Lin, Yanan
Jung, Simon
Bassetti, Claudio L
Chan, Andrew
Salmen, Anke
Hoepner, Robert
author_facet Pistor, Maximilian
Hoepner, Andreas G F
Lin, Yanan
Jung, Simon
Bassetti, Claudio L
Chan, Andrew
Salmen, Anke
Hoepner, Robert
author_sort Pistor, Maximilian
collection PubMed
description
format Online
Article
Text
id pubmed-8600608
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-86006082021-12-02 Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA’s Adverse Event Reporting System Pistor, Maximilian Hoepner, Andreas G F Lin, Yanan Jung, Simon Bassetti, Claudio L Chan, Andrew Salmen, Anke Hoepner, Robert Ann Rheum Dis Letter BMJ Publishing Group 2021-12 2021-07-20 /pmc/articles/PMC8600608/ /pubmed/34285050 http://dx.doi.org/10.1136/annrheumdis-2021-220679 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Letter
Pistor, Maximilian
Hoepner, Andreas G F
Lin, Yanan
Jung, Simon
Bassetti, Claudio L
Chan, Andrew
Salmen, Anke
Hoepner, Robert
Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA’s Adverse Event Reporting System
title Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA’s Adverse Event Reporting System
title_full Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA’s Adverse Event Reporting System
title_fullStr Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA’s Adverse Event Reporting System
title_full_unstemmed Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA’s Adverse Event Reporting System
title_short Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA’s Adverse Event Reporting System
title_sort immunotherapies and covid-19 mortality: a multidisciplinary open data analysis based on fda’s adverse event reporting system
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600608/
https://www.ncbi.nlm.nih.gov/pubmed/34285050
http://dx.doi.org/10.1136/annrheumdis-2021-220679
work_keys_str_mv AT pistormaximilian immunotherapiesandcovid19mortalityamultidisciplinaryopendataanalysisbasedonfdasadverseeventreportingsystem
AT hoepnerandreasgf immunotherapiesandcovid19mortalityamultidisciplinaryopendataanalysisbasedonfdasadverseeventreportingsystem
AT linyanan immunotherapiesandcovid19mortalityamultidisciplinaryopendataanalysisbasedonfdasadverseeventreportingsystem
AT jungsimon immunotherapiesandcovid19mortalityamultidisciplinaryopendataanalysisbasedonfdasadverseeventreportingsystem
AT bassetticlaudiol immunotherapiesandcovid19mortalityamultidisciplinaryopendataanalysisbasedonfdasadverseeventreportingsystem
AT chanandrew immunotherapiesandcovid19mortalityamultidisciplinaryopendataanalysisbasedonfdasadverseeventreportingsystem
AT salmenanke immunotherapiesandcovid19mortalityamultidisciplinaryopendataanalysisbasedonfdasadverseeventreportingsystem
AT hoepnerrobert immunotherapiesandcovid19mortalityamultidisciplinaryopendataanalysisbasedonfdasadverseeventreportingsystem

Ejemplares similares